rs57344541

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_000687.4(AHCY):​c.-34C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0106 in 1,551,714 control chromosomes in the GnomAD database, including 92 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0079 ( 11 hom., cov: 34)
Exomes 𝑓: 0.011 ( 81 hom. )

Consequence

AHCY
NM_000687.4 5_prime_UTR

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: -0.564

Publications

4 publications found
Variant links:
Genes affected
AHCY (HGNC:343): (adenosylhomocysteinase) S-adenosylhomocysteine hydrolase belongs to the adenosylhomocysteinase family. It catalyzes the reversible hydrolysis of S-adenosylhomocysteine (AdoHcy) to adenosine (Ado) and L-homocysteine (Hcy). Thus, it regulates the intracellular S-adenosylhomocysteine (SAH) concentration thought to be important for transmethylation reactions. Deficiency in this protein is one of the different causes of hypermethioninemia. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
AHCY Gene-Disease associations (from GenCC):
  • hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase
    Inheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 20-34303304-G-A is Benign according to our data. Variant chr20-34303304-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 218468.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00795 (1211/152362) while in subpopulation NFE AF = 0.0127 (864/68030). AF 95% confidence interval is 0.012. There are 11 homozygotes in GnomAd4. There are 589 alleles in the male GnomAd4 subpopulation. Median coverage is 34. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 11 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AHCYNM_000687.4 linkc.-34C>T 5_prime_UTR_variant Exon 1 of 10 ENST00000217426.7 NP_000678.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AHCYENST00000217426.7 linkc.-34C>T 5_prime_UTR_variant Exon 1 of 10 1 NM_000687.4 ENSP00000217426.2
AHCYENST00000480653.5 linkn.14C>T non_coding_transcript_exon_variant Exon 1 of 9 2
AHCYENST00000606061.1 linkn.54C>T non_coding_transcript_exon_variant Exon 1 of 3 2
AHCYENST00000538132.1 linkc.-56-7719C>T intron_variant Intron 1 of 9 2 ENSP00000442820.1

Frequencies

GnomAD3 genomes
AF:
0.00795
AC:
1211
AN:
152244
Hom.:
11
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.00190
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00432
Gnomad ASJ
AF:
0.0104
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00207
Gnomad FIN
AF:
0.0136
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0127
Gnomad OTH
AF:
0.00525
GnomAD2 exomes
AF:
0.00771
AC:
1205
AN:
156280
AF XY:
0.00782
show subpopulations
Gnomad AFR exome
AF:
0.00104
Gnomad AMR exome
AF:
0.00400
Gnomad ASJ exome
AF:
0.00856
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0146
Gnomad NFE exome
AF:
0.0120
Gnomad OTH exome
AF:
0.00747
GnomAD4 exome
AF:
0.0109
AC:
15209
AN:
1399352
Hom.:
81
Cov.:
32
AF XY:
0.0107
AC XY:
7391
AN XY:
690196
show subpopulations
African (AFR)
AF:
0.00158
AC:
50
AN:
31596
American (AMR)
AF:
0.00372
AC:
133
AN:
35710
Ashkenazi Jewish (ASJ)
AF:
0.00914
AC:
230
AN:
25176
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35746
South Asian (SAS)
AF:
0.00196
AC:
155
AN:
79232
European-Finnish (FIN)
AF:
0.0137
AC:
674
AN:
49262
Middle Eastern (MID)
AF:
0.00351
AC:
20
AN:
5698
European-Non Finnish (NFE)
AF:
0.0124
AC:
13372
AN:
1078930
Other (OTH)
AF:
0.00991
AC:
575
AN:
58002
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
779
1557
2336
3114
3893
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
502
1004
1506
2008
2510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00795
AC:
1211
AN:
152362
Hom.:
11
Cov.:
34
AF XY:
0.00791
AC XY:
589
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.00190
AC:
79
AN:
41594
American (AMR)
AF:
0.00431
AC:
66
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.0104
AC:
36
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5176
South Asian (SAS)
AF:
0.00207
AC:
10
AN:
4832
European-Finnish (FIN)
AF:
0.0136
AC:
144
AN:
10626
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0127
AC:
864
AN:
68030
Other (OTH)
AF:
0.00520
AC:
11
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
64
129
193
258
322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0113
Hom.:
3
Bravo
AF:
0.00686
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Hypermethioninemia with deficiency of S-adenosylhomocysteine hydrolase Uncertain:1Benign:1
Nov 08, 2022
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance.

not specified Benign:1
Jul 17, 2015
Genomic Diagnostic Laboratory, Division of Genomic Diagnostics, Children's Hospital of Philadelphia
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
11
DANN
Benign
0.91
PhyloP100
-0.56
PromoterAI
0.25
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs57344541; hg19: chr20-32891110; API